Professional Documents
Culture Documents
Data Set For Pha
Data Set For Pha
Data Set For Pha
INDICATORS MONTH
SEPTEMBER 11 6 26
JULY 7 13
AUGUST 20 21 28
AVERAGE OCCUPANCY
SEPTEMBER 22 14 26
JULY 135 66 71
AUGUST 73 55 75
BED OCCUPANCY RATE
SEPTEMBER 83 35 712
INDICATORS MONTH
INDICATORS MONTH
MARCH,2023 32 39 37
JAN. 2023 10 5 -
FEB, 2023 5 1 1
DEATHS
MARCH,2023 8 1 -
JAN. 2023 630 368 962
FEB, 2023 785 612 969
PATIENTS DAYS
MARCH,2023 12 5 3
JAN. 2023 20 12 32
FEB, 2023 27 14
AVERAGE OCCUPANCY
MARCH,2023 26 20 32
JAN. 2023 68 41 82
FEB, 2023 75 36
BED OCCUPANCY RATE
MARCH,2023 186 52 87
INDICATORS MONTH
INDICATORS MONTH
18 13 7 1 3 9 3
15 27 42 8 9 17 0
40 3 28 10 9 16 0
4 3 23 9 11 14 0
180 63 64 138 39 165 10
86 19 62 164 40 155 14
79 28 53 118 48 140 11
DEPARTMENTS
SURGICAL TB WARD PSYCHIATRY EMERGENCY GYNAECOLOGY NICU ICU
165 12 78 276 101 73 6
134 7 101 286 81 49 5
129 11 117 259 81 74 2
46 14 43 6 22 10 3
46 16 45 6 22 10 10
46 14 45 8 22 10 6
5 - 1 3 1 9 -
- 3 1 4 - 3 1
6 1 - 4 - 6 1
1,230 190 880 249 246 349 12
1,194 162 840 262 289 317 11
1,070 172 832 101 256 441 5
7 16 11 1 2 5 -
9 23 8 1 4 6 2
17 16 7 0 3 6 3
5 6 29 8 8 12 0
40 1 28 3 10 11 0
54 6 28 3 9 15 0
12 45 68 138 37 116 13
87 5 62 51 44 100 4
151 41 62 42 39 150 28
DEPARTMENTS
SURGICAL TB WARD PSYCHIATRY EMERGENCY GYNAECOLOGY NICU ICU
168 2 101 236 91 63 8
138 9 71 175 80 54 6
46 16 45 6 22 10 3
5 - - 5 - 12 4
2 - - 5 - 4 2
2 1 - 6 - 8 -
1,186 76 903 200 229 346 11
1,269 166 977 266 306 378 13
16 42 9 1 3 7 7
38 3 30 7 8 12 0
32 4 26 7 8 11 2
42 6 33 9 10 12 0
23 21 67 111 35 115 6
83 26 57 122 36 113 15
DEPARTMENTS
DEPARTMENTS
SURGICAL TB WARD PSYCHIATRY EMERGENCY GYNAECOLOGY NICU ICU
104 4 114 265 68 54 0
124 5 125 271 104 61 4
46 18 45 6 22 10 -
46 20 45 6 22 10 3
5 - 1 4 1 8 -
- 2 2 10 1 10 1
22 21 9 1 4 7 -
19 27 9 1 3 5 4
37 3 32 7 9 13 -
40 5 36 10 11 10 1
7 4
4 0 172
3 173
2 160.50
12 3 62.30
22 64.40
11 59
9
16 -
16
12
1 -
2
1
71 -
57
57
12 -
8
6
2 -
3
2
15 -
17
16
PRIVATE WING EYE TOTAL
13 53 1119
1 0 1320
12 43 258
16 - 266
1 - 34
1 40
83 - 9,611
45 - 5,693
6 56 9,667
45 - 4
3 2
2 - 184
231 4
9 - 69%
Kabale RRH FY 2022/2023
DEPARTMENTS JULY AUG SEPT OCT NOV DEC JAN
OUT PATIENTS
NEW OPD ATTENDANCES 4197 4035 3636 7186 4443 3061 3945
RE-ATTENDANCES 2756 3166 2694 3292 3022 2175 2700
REFERALS TO UNIT 1 2 25 156 19 139 6
REFERALS FROM UNIT 12 5 14 37 21 25 17
SURGICAL OPD 103 0 183 95 110 42 118
HEPATITIS CLINIC 0 0 0 0 0 0 0
MEDICAL OPD 0 0 0 0 0 0 0
PAEDIATRIC OPD 56 79 64 178 114 206 123
PSYCHATRIC DEPARTMENT 679 747 697 650 647 650 601
DENTAL 223 230 307 297 375 305 341
GASTRO ENTOLOGY 0 0 0 0 0 0 0
PALLIATIVE CARE 16 14 11 8 9 12 7
UROLOGY 0 0 0 0 0 0 0
EYE CLINIC 256 278 328 265 231 244 221
ENT 153 176 161 161 17 76 215
DIABETES 241 9 258 235 325 229 233
HTN 731 68 253 338 324 408 348
EYE CLINIC 256 278 328 262 231 244 219
CHILDRENS CLINIC 138 188 174 178 114 206 151
PRIVATE WING 104 98 95 119 95 96 104
HIV CLINIC 919 1153 796 1197 1035 718 1024
CERVICAL CANCER SCREENING 30 0 0 37 33 64 74
BREAST CANCER SCREENING 31 0 0 37 33 64 0
GYNAECOLOGY 91 214 0 145 162 64 98
TB 10 51 47 68 61 58 44
HIV DATA
HCT 767 786 667 462 516 253 615
NUMBER OF INDIVIDUAL TESTED 767 858 667 462 516 253 615
NUMBER WHO RECEIVED HIV RE 767 858 667 458 516 253 615
SAFE MALE CIRCUMCISION 338 744 215 92 0 0 92
PRE ART 19 23 16 0 0 0 0
ACTIVE ON ART 3616 3609 3610 3605 3452 3585 3528
TESTED HIV POSITIVE 17 17 16 5 7 12 14
PREVENTIVE AND REHABILITATION
ORTHOPEDICS 364 321 350 321 419 261 370
FOOT AND HAND (CLUB FOOT) 14 18 21 16 15 14 144
SOCIAL WORK ACTIVITIES 0 0 0 0 0 0 0
OCCUPATIONAL THERAPY 96 21 80 78 97 61 80
PHYSIOTHERAPY 284 243 293 292 293 116 262
TEENAGE / ADOLESCENT SERVICE 426 567 568 833 764 389 410
DIAGNOSTICS
LABORATORY CONTACTS 6275 5698 7994 7754 5906 3998 5368
BLOOD TRANSFUSION 103 75 79 85 115 83 101
PATHOLOGY 0 0 0 0 0 0 0
RADIOLOGY
ULTRASOUND GENERAL 542 279 498 603 567 460 553
ULTRA SOUND PRIVATE 20 15 13 21
CT SCAN (soon coming) 0 0 0 0 0 0 0
FULL WAIVER 0 0 0 0 0 0 0
PARTIALLY WAIVED 0 0 0 0 0 0 0
X-RAY GENERAL 292 33 37 67 103 123 135
X-RAY PRIVATE 0 0 0 0 0 0 5
THEATRE
CEASARIAN SECTION 135 149 147 142 100 110 122
MAJOR OPERATION 182 180 179 288 197 233 233
MINOR OPERATIONS 104 185 64 0 0 0 0
EVACUATION 42 22 26 42 51 32 27
MATERNAL AND CHILD HEALTH
ANC 1ST VISIT 109 115 92 121 119 84 127
ANC 4TH VISIT 74 89 97 66 74 71 69
4+ VISIT 98 512 96 114 105 45 100
8TH VISIT 5 0 8 15 7 12 14
NEW AND RE-ATTENDANCES 495 512 469 443 464 403 489
HIGH RISK MOTHERS 20 23 24 0 3 6 4
POSTNATAL 274 324 331 290 288 277 383
PMTCT 137 224 139 152 168 169 146
FEMALE STERILIZATION 0 0 0 0 0 0 0
MALE STERILIZATION 0 0 0 0 0 0 0
INPLANT NEW USERS 20 21 24 14 19 15 23
INPLANT RE-VISITS 17 20 33 41 27 1 9
INPLANT REMOVAL 24 23 12 41 19 16 23
FAMILY PLANNING NEW VISITS 88 80 65 51 67 42 57
FAMILY PLANNING RE-VISITS 57 172 107 220 149 141 29
FAMILY PLANNING TOTALS 169 276 172 271 216 183 86
MATERNITY
ADMISSIONS 297 355 310 311 377 297 374
REFERALS TO UNIT 77 115 83 82 78 96 128
REFERALS FROM UNIT 0 4 0 0 0 0 0
DELIVERIES IN UNIT 276 313 294 280 290 280 329
LIVE BIRTHS IN UNIT 277 311 287 244 360 282 322
BIRTH ASPHXIA 27 28 16 18 6 18 23
FRESH STILL BIRTH 5 3 6 2 3 7 4
MACERATED STILL BIRTH 3 4 6 2 1 2 3
NEW BORN DEATH 3 4 7 1 3 6 8
MATERNAL DEATH 0 0 0 0 1 2 0
BABIES WITH WEIGHT <2.5KG 25 23 15 18 16 24 10
IMMUNISATION
CHILD IMMUNISATION 1600 904 1658 10816 1323 1323 727
TETANUS IMMUNISATION 41 301 85 111 71 46 101
NO. OF VACCINE AVAILABLE 1246 1424 1067 1302 689 1226 2198
HOSPITAL AMBULANCE SERVICES 0 0 0 0
FEB MARCH APRIL MAY JUNE TOTAL
3084 3861
1541 2913
9 7
24 11
78 127 104 66
3 0 0 0
0 0 0 0
127 257 131 303
571 704
264 240 143 166
0 0 0 0
46 25
0 0 0 0
169 271 1430 303
169 200 166 269
240 254
340 444
196 271 1430 303 xtg[ hy
166 168
91 118 72 62
513 1565
0 116
62 116
91 112 88 131
38 56
TD01.
Td1-Dose 22 0 25 0 0
1
TD02.
Td2-Dose 18 0 5 0 0
2
TD03.
Td3-Dose 6 0 0 0 0
3
TD04.
Td4-Dose 2 0 0 0 0
4
TD05.
Td5-Dose 0 0 0 0 0
5
Doses
Static Outreach Static Outreach
CL02.
Protectio
n At Birth 307 0
for
TT(PAB)
CL03.
307 0 0 0
Polio 0
CL04.
38 0 0 0
Polio 1
CL05. 34 0 0 0
Polio 2
CL06.
30 0 0 0
Polio 3
CL07. IPV 68 0 0 0
CL08.
DPT-
38 0 0 0
HepB+Hib
1
CL09.
DPT-
34 0 0 0
HepB+Hib
2
CL10.
DPT-
30 0 0 0
HepB+Hib
3
CL11. PCV
1 38 0 0 0
CL12. PCV
34 0 0 0
2
CL13. PCV
30 0 0 0
3
CL14.
Rotavirus 38 0
1 Vaccine
CL15.
Rotavirus 34 0
2 Vaccine
CL16.
Measles 46 0 0 0
(MR1)
CL17.
Measles 2 0 8
(MR2)
CL18.
Fully
immunize 46 0
d by 1
year
CL19.
Received
LLIN at
30 0 0 0
Child
Immuniza
tion
Doses wasted
Antigen Open Balance (A) Received (B) Closing Balance (C)
WT01.
BCG 560 400 160 0
WT02.
Polio 140 500 300 0
(OPV)
WT03.
45 50 75 0
IPV
WT04.
DPT+Hep 220 0 120 0
B+Hib
WT05.
177 200 224 0
PCV
WT06.
134 0 92 0
Rotavirus
WT07.
290 200 190 0
Measles
WT08. Td 200 0 120 0
WT09.
0 0 0 0
HPV
WT10.
Yellow 0 0 0 0
Fever
Under 1
Doses
Static Outreach
CL02.
Protectio
n At Birth 311 0
for
TT(PAB)
CL03.
311 0
Polio 0
CL04.
41 0
Polio 1
CL05.
Polio 2 35 0
CL06.
5 – 14 Years 36 0
Polio 3
CL08.
DPT-
41 0
HepB+Hib
1
CL09.
DPT-
HepB+Hib 35 0
2
CL10.
DPT-
36 0
HepB+Hib
3
CL11. PCV
41 0
1
CL12. PCV 35 0
2
CL13. PCV
36 0
3
CL14.
Rotavirus 41 0
1 Vaccine
CL15.
Rotavirus 35 0
2 Vaccine
CL16.
Measles 32 0
(MR1)
CL17.
Measles 2
(MR2)
CL18.
Fully
immunize 32 0
d by 1
year
CL19.
Received
LLIN at
36 0
Child
Immuniza
tion
2.7.4 VACCINE AVAILABILITY AND WASTAGE
WT01.
860 4
BCG
WT02.
Polio 360 2
(OPV)
WT03.
55
IPV
WT04.
0 0 DPT+Hep 120 2
B+Hib
WT05.
21 2
PCV
WT06.
sted 19 2
Rotavirus
0 493 WT08. Td 0 2
WT09.
0 0 HPV 0
WT10.
0 0 Yellow 0
Fever
0 0
0 0
1
1-4 Years 5 – 14 Years
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
22 0
0 0 0 0 0
STAGE
Doses wasted
Received (B) Closing Balance (C)
Doses in Open Vials
Doses in Closed Vials (CV)
(OV)
200 160 0 0
50 45 0 0
200 220 0 0
200 134 0 0
200 134 0 0
200 290 0 16
200 110 0 0
0 0 0 0
0 0 0 0
ture alarms 0
ure alarms 0
rigerators available 1
3.1
Below 15 Below 15
0 0 Obstetrics/Gynaecol
years years
ogy
Below 15 Below 15
0 0 0 0
years years
SP05.
Hysterect
15-19 15-19 omy
years 0 0 years 0 0
Below 15 Below 15
years 0 0 years 0 0 PR01. Skin grafting
FP03.Oral
: Ovrette FP13.
or IUD-
another Copper-T
POP
15-19 15-19
0 0 0 0 3.4 Paediatric Surgery
years years
FP03.Oral
: Ovrette FP13.
or IUD-
another 20-24 Copper-T 20-24 PS01. Ramsteidts
POP 0 0 0 1
years years Procedure
PS02. Excision of
25-49 0 0 25-49 4 4 Sacro-coccygeal
years years
teratome
PS03. PSARP
50+ years 0 0 50+ years 0 0 (Posterior Saggital
Anorectoplasty)
Below 15 Below 15
0 0 PS04. Pull through
years years
FP04.Oral
FP14.
: IUD-
Levonoge
Hormonal
steral
25-49 25-49 PS07. Diaphragmatic
3 0
years years hernia repair
PS08. Tracheal-
50+ years 0 0 50+ years eosophageal fistula
repair
FP15.
FP05.Oral
: Others FAM-SDM
method
15-19 15-19 PS10. Congenital
0 0
years years hernia repair
FP15.
FP05.Oral
FAM-SDM
: Others 20-24 method 20-24 0 0 PS11. Cut down
years years
25-49 25-49
0 0 3.5 Ocular surgery
years years
OC01. Cataract
50+ years 50+ years 0 0
Surgery
FP06.
Injectable
DMPA(IM FP16.
e.g 20-24 20-24
18 22 FAM-LAM 0 0 OC04. Oculoplasty
Depo)3 years years
months
OC06. Opthalmic
50+ years 0 0 50+ years 0 0
laser Interventions
ES01.Thyr
50+ years 0 0 50+ years 0 0 oidectom
y
Below 15 Below 15 ES02.Mas
0 0
years years tectomy
ES03.Adre
15-19 15-19
0 0 nalectom
years FP18. years
y
FP08. 20-24 Emergenc 20-24 3.10
y 0 0
Injection years years Urology
UR01.Ope
2 months 25-49 Contrace 25-49 n
ptive Pills 3 0
years years Prostatec
users tomy
UR02.
Radical
50+ years 50+ years 0 0
prostatec
tomy
UR04.Ren
15-19 15-19 al surgery
0 0
years years (Nephrect
omy etc.)
FP09. FP19.
Injection Female UR05.
1 month 20-24 Condoms 20-24 Urinary
0 0
years years stone
Surgery
UR09.
Testicular
Surgery
15-19 15-19
0 0 0 0 (Orchidop
years years
exy,
ochidecto
my ,BSO )
FP10. 3 UR10.
year Urine
implant 20-24 0 0 FP20.
20-24
0 0
diversion
(e.g. years years (SPC,
implanan Male Nephrost
on NXT, Condoms omy)
Levo
plant)
implant
FP20.
(e.g.
Male
implanan
Condoms
on NXT,
Levo
plant)
UR11.
25-49 25-49
0 0 0 0 Urethropl
years years
asty
UR12.
50+ years 0 0 50+ years 0 0 Penectom
y
UR13.
Genitopla
sty
UR14.
Varicocoe
lectomy
UR15.
Hypospad
ias repair
UR16.
Epispadia
s repair
UR17.
Bladder
exstropy
UR18.
Kidney
transplant
3. SURGICAL PROCEDURES 3. SURGICAL PROCEDURES
OR04. OR04.
SP04.Laparotomy 10 Arthroto 0 SP04.Laparotomy 19 Arthroto
my my
OR05. OR05.
Total Total
Limb Limb
Hysterect 6 0 Hysterect 9
disarticula disarticula
omy omy
tion SP05. tion
OR06. Hysterect OR06.
Sub-Total omy Sub-Total
Bone Bone
Hysterect 0 reconstru 0 Hysterect 1 reconstru
omy omy
ction ction
OR07. OR07.
3.2 Cardiothoracic Surgery Amputati 1 3.2 Cardiothoracic Surgery Amputati
on on
OR08. OR08.
Corrective Corrective
CS01.Thoracotomy 0 osteotomi 0 CS01.Thoracotomy 0 osteotomi
es es
OR09. OR09.
3.3 Plastic/ reconstructive 3.3 Plastic/ reconstructive
Arthrodes 0 Arthrodes
surgery surgery
is is
OR10. OR10.
PR01. Skin grafting 0 Arthrosco 0 PR01. Skin grafting 2 Arthrosco
py py
OR11. OR11.
3.4 Paediatric Surgery Internal 1 3.4 Paediatric Surgery Internal
fixation fixation
OR12. OR12.
PS01. Ramsteidts Soft PS01. Ramsteidts Soft
0 0 0
Procedure tissue Procedure tissue
releases releases
NS02. NS02.
PS04. Pull through 0 0 PS04. Pull through 0
Burr Hole Burr Hole
NS03. NS03.
PS05. Kasai PS05. Kasai
0 Craniopla 0 0 Craniopla
Procedure Procedure
sty sty
NS04. NS04.
PS06. Gastroschisis PS06. Gastroschisis
0 Microdisc 0 0 Microdisc
repair ectomy repair ectomy
NS05. NS05.
ETV/CPC ETV/CPC
(Endosco (Endosco
pic pic
PS07. Diaphragmatic
0 3 Ventric
PS07. Diaphragmatic
0 3 Ventric
rd rd
0
hernia repair ulostomy/ hernia repair ulostomy/
choroid choroid
plexus plexus
cauteriza cauteriza
tion) tion)
NS06. NS06.
PS08. Tracheal- PS08. Tracheal-
Spina- Spina-
eosophageal fistula 0 bifida 0 eosophageal fistula 0 bifida
repair repair
surgery surgery
NS07. NS07.
EVD EVD
PS09. Congenital (External PS09. Congenital (External
0 0 0
cyst excision Ventricula cyst excision Ventricula
r r
Drainage) Drainage)
NS08. NS08.
Elevation Elevation
PS10. Congenital of PS10. Congenital of
0 0 0
hernia repair depresse hernia repair depresse
d skull d skull
fracture
NS09. VP fracture
NS09. VP
PS11. Cut down 0 0 PS11. Cut down 0
shunts shunts
3.5 Ocular surgery 3.8 ENT Surgery 3.5 Ocular surgery 3.8 ENT Surgery
TS01. TS01.
OC01. Cataract OC01. Cataract
46 Tracheost 0 0 Tracheost
Surgery omy Surgery omy
TS02. TS02.
OC02. Glaucoma OC02. Glaucoma
3 Adenoton 3 0 Adenoton
Surgery Surgery
sillectomy sillectomy
TS03. TS03.
OC03. Orbital OC03. Orbital
0 Nasal 0 0 Nasal
Surgery surgery Surgery surgery
TS04. TS04.
Laryngolo Laryngolo
OC04. Oculoplasty 0 0 OC04. Oculoplasty 0
gical gical
surgery surgery
TS05. TS05.
OC05. Eye lid OC05. Eye lid
0 Otological 0 0 Otological
Operation Operation
surgery surgery
3.11 3.11
3.9
NUMBER Gastro- NUMBER NUMBER Gastro-
Endocrine
S intestinal S S intestinal
Surgery
tract tract
GI07. GI07.
UR03.End
0 Colectom 0 0 Colectom
o-urology
y y
UR04.Ren
GI08. GI08.
al surgery
0 Laproscop 3 0 Laproscop
ic Surgery (Nephrect ic Surgery
omy etc.)
UR05.
GI09. GI09.
Urinary
0 Endoscopi 0 0 Endoscopi
stone
c Surgery c Surgery
Surgery
UR09.
Testicular
Surgery
0 3.12 Oral surgery (Orchidop 3 3.12 Oral surgery
exy,
ochidecto
my ,BSO )
UR10.
OS01. Urine OS01.
Hemi- diversion Hemi-
0 0 0
Mandibul (SPC, Mandibul
ectomy Nephrost ectomy
omy)
OS02. OS02.
UR11.
Total Total
0 0 Urethropl 0
Mandibul Mandibul
asty
ectomy ectomy
OS03. OS03.
Segmenta Segmenta
UR12.
l l
0 0 Penectom 0
Resection y Resection
of of
Mandible Mandible
OS06. OS06.
UR15.
Partial- Partial-
0 0 Hypospad 0
glossecto glossecto
ias repair
my my
OS07. OS07.
UR16.
Excision Excision
0 4 Epispadia 0
biopsy of s repair biopsy of
tumour tumour
OT02. OT02.
Incision Incision
and and
0
drainage drainage
of of
abscesses abscesses
OT03. OT03.
Safe Male Safe Male
0
Circumcisi Circumcisi
on on
OT04. OT04.
13
Others Others
0.2 LABORATORY ROUTINE TESTS
NUMBER
10.2.1 Number of Routine Tests Done in Facility Laboratory
S
HE01. Hb
(Non SR01.VDR
0 0 121 6
automate L/ RPR
d)
HE02. SR02.TPH
0 688 121 6
CBC A
HE03. SR03.Shig
1 Film 4 ella 0 0
Comment Dysentery
SR04.
0 HE04. ESR 4 Hepatitis 40 1
B SAgS
HE05.
SR05.
4 Bleeding 0 121 7
Brucella
time
SR06.
HE06.
Pregnanc
0 Prothrom 0 44 10
y Test
bin time
(HCG)
HE07.
SR07.
0 Clotting 0 22 0
CRAG
time
SR08.
HE08.
0 Sickle Cell 0 Rheumat 19 0
oid factor
HE09. SR09. Hep
0 0 0 0
Others B Core Ag
SR10. Hep
0 BLOOD TRANSFUSION 0 0
C
BT01.
3.7 Neuro surgery AHG 0 SR11. Hep 0 0
(Combs A
Test)
BT02.
0 ABO 94 MICROBI
Grouping OLOGY
BT03. (CSF,
URINE,
0 Rhesus 94
STOOL,
Grouping
BLOOD,
SPUTUM,
MB01.
SWABS)
BT04.
Auramine
0 Cross 94 22 1
(FM) for
Matching
AFBs
MB02. ZN
0 IMMUNOLOGY 0 0
for AFBs
MB03.
IG01. CD4
0 48 Leishman 0 0
test
Stain
IG02.
MB04.
0 Viral Load 0 Gram 0 0
Test
IG03. Hep
MB05.
0 B Viral 11 0 0
India Ink
Load
MB06.
IG04. TB Urine
0 0 245 33
LAM Microsco
py
MB07.
0 MOLECULAR Wet 280 57
Preps
ML01. TB MB08.
3.8 ENT Surgery Genexper MTB+ 9 0 0
Others
t (For 633
Genexper
0 t sites RR 0
only)
ML02.
Latent TB
5 0 0
Infection
test
ML03. TB
0 0 0
Lamp Test
10.3
0 PARASITOLOGY(Blood) CLINICAL
CHEMISTRY
PS01.
Malaria
0 151 8 Renal Profile
Microsco
py
PS02. RP01.
0 Malaria 201 12 197
Urea
RDTs
PS03.
0 Trypanos 0 0 RP02. 7
Calcium
oma
PS04. RP03.
Microfilari 0 0 Potassiu 7
a m
PS05.
RP04.
Leishmani 0 0 Sodium 7
a
PS06. RP05.
NUMBER
Trichinell 0 0 Creatinin 197
S
a e
PS07.
0 0 0 Liver Profile
Borrellia
0 STOOL MICROSCOPY LP01. ALT 168
MS01.
0 Entamoeb 0 LP02. AST 168
a
MS02.
LP03.
0 Giardia 0 122
MS03. Albumin
LP04.
Lumblia
0 Cryptospo 0 Total 122
ridium Protein
Lipid/
MS04.
0 0 Thyroid
Isospora
Profile
MS05. LC01.
0 Cyclospor 0 Triglyceri 11
a des
MS06. LC02.
0 Strongyloi 0 Cholester 11
des ol
MS07.
LC03.
0 Shistosom 0 3
Free T3
a
MS08. LC04.
0 0 3
Taenia Free T4
MS09.
7 0 LC05. TSH 3
Askaris
Other
MS10.
Clinical
0 Hookwor 0
Chemistry
m
Tests
CX01.
MS11. Alkaline
3.12 Oral surgery 0 13
Trichuris Phosphat
e
MS12.
CX02.
0 Other 0 Amylase 13
parasites
Total
Tests
Done for CX03.
0 23 564
Stool Glucose
Microsco
py
CX04.
0 Culture Sensitivity Total 152
Bilirubin
CS01. CX05.
0 10 153
Blood Lipase
CS02.
0 12 CX06. AFP 11
Urine
CS03. CX07.
0 0 57
Stool Others
CS04.
2 Genital 5
Swabs
3.13 Other Un
CS05.
classified Surgical 1
Procedures Sputum
HP04. HIV
Syphilis 183 0 0
DUO
HP05. HIV
Oral 0 0 0 0 0 0
Testing
0.2 LABORATORY ROUTINE TESTS
Number
Lab Tests Number Positive
Done
HEMATOLOGY (BLOOD)
HE01. Hb
(Non
0
automate
d)
HE02.
531
CBC
HE03.
Film 0
Comment
HE04. ESR 1
HE05.
Bleeding 0
time
HE06.
Prothrom 0
bin time
HE07.
Clotting 0
time
HE08.
Sickle Cell 0
HE09.
0
Others
BLOOD TRANSFUSION
BT01.
AHG 0
(Combs
Test)
BT02.
ABO 159
Grouping
BT03.
Rhesus 159
Grouping
BT04.
Cross 97
Matching
IMMUNOLOGY
IG01. CD4
20
test
IG02.
Viral Load 295
Test
IG03. Hep
B Viral 4
Load
IG04. TB
0
LAM
MOLECULAR
ML01. TB
Genexper MTB+
t (For 526
Genexper
t sites RR
only)
ML02.
Latent TB
27 0
Infection
test
ML03. TB
38 0
Lamp Test
PARASITOLOGY(Blood)
PS01.
Malaria
128 5
Microsco
py
PS02.
Malaria 238 11
RDTs
PS03.
Trypanos 0 0
oma
PS04.
Microfilari 0 0
a
PS05.
Leishmani 0 0
a
PS06.
Trichinell 0 0
a
PS07.
0 0
Borrellia
STOOL MICROSCOPY
MS01.
Entamoeb 0
a
MS02.
Giardia 0
MS03.
Lumblia
Cryptospo 0
ridium
MS04.
0
Isospora
MS05.
Cyclospor 0
a
MS06.
Strongyloi 0
des
MS07.
Shistosom 0
a
MS08.
0
Taenia
MS09.
0
Askaris
MS10.
Hookwor 0
m
MS11.
0
Trichuris
MS12.
Other 0
parasites
Total
Tests
Done for
8
Stool
Microsco
py
Culture Sensitivity
CS01.
10
Blood
CS02.
15
Urine
CS03.
4
Stool
CS04.
Genital 17
Swabs
CS05.
0
Sputum
DNA
Inconclusi Repeat
IQC EQA Total Confirme Category HCT eMTCT
ve Results Testers
d Tests
HP01.
0 0 1011 0 Determin 527 214
e
HP02.
0 0 12 0 32 5
Statpak
HP03. SD
0 0 0 0 0 0
Bioline
HP04. HIV
0 0 183 0 Syphilis 0
DUO
HP05. HIV
0 0 0 0 Oral 0 0
Testing
NE TESTS
Number Number
Number Positive Lab Tests
Done Positive
OD) SEROLOGY
SR01.VDR
453 12
L/ RPR
SR02.TPH
0 0
A
SR03.Shig
ella 0 0
Dysentery
SR04.
Hepatitis 126 2
B SAgS
SR05.
72 6
Brucella
SR06.
Pregnanc
65 19
y Test
(HCG)
SR07.
4 1
CRAG
SR08.
Rheumat 46 3
oid factor
SR09. Hep
0 0
B Core Ag
SR10. Hep
ON 0 0
C
SR11. Hep 0 0
A
MICROBI
OLOGY
(CSF,
URINE,
STOOL,
BLOOD,
SPUTUM,
MB01.
SWABS)
Auramine
24 1
(FM) for
AFBs
MB02. ZN
0 0
for AFBs
MB03.
Leishman 0 0
Stain
MB04.
Gram 42 14
MB05.
0 0
India Ink
MB06.
Urine
274 82
Microsco
py
MB07.
Wet 294 87
Preps
MB08.
18 0 0
Others
10.3
od) CLINICAL
CHEMISTRY
5 Renal Profile
RP01.
11 89
Urea
0 RP02. 15
Calcium
RP03.
0 Potassiu 15
m
RP04.
0 Sodium 15
RP05.
0 Creatinin 89
e
0 Liver Profile
Y LP01. ALT 92
0 LP02. AST 92
LP03.
0 82
Albumin
LP04.
0 Total 82
Protein
Lipid/
0 Thyroid
Profile
LC01.
0 Triglyceri 26
des
LC02.
0 Cholester 26
ol
LC03.
0 26
Free T3
LC04.
0 26
Free T4
0 LC05. TSH 0
Other
Clinical
0
Chemistry
Tests
CX01.
Alkaline
0 2
Phosphat
e
CX02.
0 Amylase 0
CX03.
834
Glucose
CX04.
Total 79
Bilirubin
CX05.
79
Lipase
CX06. AFP 0
CX07.
11
Others
TEST BY PURPOSE
0 0 0 0 0 0 37 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0 0 0
Tested for HIV 6 6 11 23 2
HT03.
Total
number
of
Individual
s New HIV positive 0 2
Individual
s
M F M F M
Tested for
4 5 9 9 2
HIV
Health Facility
HT04. New HIV
1
Number positive
of
individual Linked to
s (by PITC 1
HIV care
Testing
approach) Tested for
1 2 8
HIV
New HIV
Community
positive
Linked to
HIV care
Tested for
1 1 0 6 0
HIV
New HIV
HT05. Health Facility positive 1
Number
of Linked to
1
individual HIV care
s (by Tested for
CICT/VICT HIV
Testing
approach Community New HIV
positive
Linked to
HIV care
8 5 18 25 55 51 91 26 67 30
0 0 0 0 2 1 0 2
0 0 0 0 2 1 0 2
F M F M F M F M F M
1 5 7 30 10 76 13 56 15
7 3 4 4 8 7 2 2
1 1 9 8 14 21 37 13 17 15
1 1 1
1 1 1
HT03.
Total
number
of
Individual
s
HT04.
Number
of
individual
s (by PITC
Testing
approach)
HT05.
Number
of
individual
s (by
HT05.
Number
of
individual
s (by
CICT/VICT
Testing
approach
55 15 36 21 21 7 18 42 47
1 1 0 1 0 1 1 1 3
1 1 0 1 0 1 1 1 3
F M F M F M F M F
48 6 30 19 19 3 13 29 23
1 1
1 1
5 1 2
1 2
1 2
13 4 6 4 4 4 5 13 23
1 1 1
1 1 1
Tested for HIV 4 7 11 20 16 18 8
M F M F M F M
Tested for
3 5 6 11 7 2 3
HIV
New HIV
0 0 0 0 0 0 0
Health Facility positive
Linked to
HIV care 0 0 0 0 0 0 0
Tested for
0 2 3 7 9 14 3
HIV
New HIV
0 0 0 0 0 0 0
Community positive
Linked to
0 0 0 0 0 0 0
HIV care
Tested for
HIV 1 0 2 2 0 2 2
Health Facility
Health Facility New HIV
0 0 0 0 0 0 0
positive
Linked to
0 0 0 0 0 0 0
HIV care
Tested for 0 0 0 0 0 0 0
HIV
New HIV
Community 0 0 0 0 0 0 0
positive
Linked to
0 0 0 0 0 0 0
HIV care
20 12 49 56 185 37 100 46 101 29
0 0 0 0 2 2 3 0 3 1
0 0 0 0 2 2 3 0 3 1
F M F M F M F M F M
5 4 34 21 122 13 66 9 48 13
0 0 0 0 2 1 2 0 0 1
0 0 0 0 2 1 2 0 0 1
14 4 4 9 6 4 6 5 1 1
0 0 0 0 0 0 0 0 1 0
0 0 0 0 0 0 0 0 1 0
1 4 11 26 57 20 28 32 52 15
0 0 0 0 0 1 1 0 2 0
0 0 0 0 0 1 1 0 2 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
87 55 77 26 28 37 47
1 0 0 0 0 0 0
1 0 0 0 0 0 0
F M F M F M F
59 20 33 14 15 30 34
1 0 0 0 0 0 0
1 0 0 0 0 0 0
2 0 0 0 2 5 2
0 0 0 0 0 0 0
0 0 0 0 0 0 0
26 35 44 12 11 2 11
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
2.6 FAMILY PLANNING NEW USERS REVISITS 2.6 FAMILY PLANNING NEW USERS REVISITS
METHODS METHODS
Below 15 Below 15
0 0
years years
15-19 15-19
0 0 FP11. 4
years years
FP01:Oral year
Lo- 20-24 implant 20-24
Femenal years 3 0 (e.g. Sino
years
plant)
25-49 25-49
0 7
years years
50+ years 0 0 50+ years
Below 15 Below 15
0 0 0 0
years years
15-19 15-19
0 0 FP12. 5 0 0
FP02. years years
year
Oral:
implant
Microgyn 20-24 0 0 (e.g.
20-24
4 2
on years years
Jadella)
25-49 25-49
0 0 5 5
years years
50+ years 0 0 50+ years 0 0
Below 15 Below 15
0 0 0 0
years years
25-49 25-49
0 0
years years
50+ years 50+ years 0 0
Below 15 Below 15
0 0 0 0
years years
FP10. 3
year 15-19 15-19
0 0 0 0
implant years FP20. years
(e.g.
20-24 Male
implanan 1 2 Condoms 20-24 0 0
on NXT, years years
Levo
plant)
year
implant
FP20.
(e.g.
Male
implanan
Condoms
on NXT,
Levo 25-49 25-49
plant) 4 0 0 0
years years
50+ years 0 0 50+ years 0 0
EMERGENCY SERVICES FY 2020/2021
Positive 0 0 0
RDT 0 0 1
Tests
0 0 0
Negative
Positive 0 0 1
Admissi 0 0 1
ons
Discharg 0 0 1
e
Death 0 0 0
Run 0 0 0
away
Home 0 0 0
care
0 0 0
Staff
trainings
Remark
Mar Apr May Jun
s